{"id":"oxabact-oc5-oxalobacter-formigenes-hc-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal symptoms"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Oxalobacter formigenes HC-1 metabolizes oxalate in the gut, thereby decreasing the amount of oxalate available for absorption into the bloodstream. This can help reduce the risk of hyperoxaluria and related complications such as kidney stones.","oneSentence":"Oxabact OC5 is a live biotherapeutic product that works by colonizing the gut with Oxalobacter formigenes HC-1, which degrades oxalate, reducing its absorption and systemic levels.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:50:52.014Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Primary Hyperoxaluria Type 1 (PH1)"}]},"trialDetails":[{"nctId":"NCT03116685","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria","status":"COMPLETED","sponsor":"OxThera","startDate":"2018-01-09","conditions":"Primary Hyperoxaluria","enrollment":25},{"nctId":"NCT03938272","phase":"PHASE3","title":"An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria","status":"TERMINATED","sponsor":"OxThera","startDate":"2019-03-14","conditions":"Hyperoxaluria, Primary","enrollment":22}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Oxabact OC5 - Oxalobacter formigenes HC-1","genericName":"Oxabact OC5 - Oxalobacter formigenes HC-1","companyName":"OxThera","companyId":"oxthera","modality":"Biologic","firstApprovalDate":"","aiSummary":"Oxabact OC5 is a live biotherapeutic product that works by colonizing the gut with Oxalobacter formigenes HC-1, which degrades oxalate, reducing its absorption and systemic levels. Used for Primary Hyperoxaluria Type 1 (PH1).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}